Clinical Trial: Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175220) titled 'Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects' on Sept. 09.

Brief Summary: Evaluate the safety, tolerability, and objective response rate (ORR) of SHR2554 tablets in combination with other anti-tumor treatments in subjects with locally advanced or metastatic non-small cell lung cancer

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Locally Advanced or Metastatic Non-small Cell Lung Cancer

Intervention: DRUG: SHR2554; SHR-A2102

SHR2554 tablets combined with SHR-A2102 for injection, with a cycle of 21 days

DRUG: SHR2554; Adabelimu...